Bausch + Lomb

Bausch + Lomb is one of the most established and trusted names in eye health, with a history spanning more than 170 years. Founded in 1853 in Rochester, New York, the company has grown from a small optical goods shop into a global leader in the science and business of vision care. Today, Bausch + Lomb operates across more than 100 countries, bringing innovation to patients and eye care professionals around the world.

The company offers one of the broadest portfolios in the eye health industry, spanning surgical, pharmaceutical, and vision care categories. Their product lineup includes intraocular lenses, viscoelastics, and surgical instrumentation, alongside a wide range of contact lenses, lens care solutions, and ocular pharmaceuticals addressing conditions from dry eye and retinal disease to glaucoma and beyond. 

As patient expectations rise, the pace of clinical innovation shows no signs of slowing down. Bausch + Lomb has kept pace with both, staying close to the eye care community not just as a product company, but as a genuine partner in education, collaboration, and the ongoing work of helping people see better.

Qlosi works through pupil modulation, using a low-dose formulation of pilocarpine to create a pinhole effect that increases depth of field and improves near visual acuity. It is available by prescription in the U.S. and may be dosed once or twice daily per eye. Full prescribing information is available at qlosiecp.com/.

Orasis is led by a team of experienced pharmaceutical and eye care industry executives whose expertise spans clinical development, regulatory affairs, and commercial strategy. Backed by a group of leading life science and healthcare investors, the company is focused on delivering meaningful, accessible solutions for patients and the eye care professionals who treat them.